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CRE sites in vitro and in vivo. Mithramycin A, a 
competitive inhibitor of Spl binding to DNA, re- 
duced MIF promoter activity and mRNA levels in 
THP-1 ceils, whereas expression of Spl in Spl- 
deficient Sf9 insect ceils increased promoter activ- 
ity. Albeit located in a CpG island, MIF expression 
was not modulated by DNA methy[ation of its CpG 
sites. Steady state MIF mRNA levels correlated with 
mRNA haft-lives in HeLa, A549, HaCat and THP-1 
ceils suggesting that mRNA stability is a key deter- 
minant of ceil-specific post-transcriptional control 
of MIF expression. 
Conclusions: The present findings provide evidence 
imp[icating Spl and CREB and mRNA stabi[ity in 
transcriptional and post-transcriptional regulation 
of human MIF gene expression. The identification 
of the factors involved in the regulation of the 
constitutive MIF gene expression may provide im- 
portant insights into the molecular mechanisms 
leading to increased MIF expression in cancer and 
in inflammatory and auto-immune diseases. 
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Modulation of Innate Immunity by the Histone 
Deacetylase Inhibitor Trichostatin A (TSA) 
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Reymond, P. Renner, D. Le Roy, T. Ca[andra. 
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Switzerland 
Background: Histone deacety[ases (HDACs) are 
regulators of chromatin structure and gene expres- 
sion. Originally investigated as anticancer drugs, 
HDAC inhibitors (HDI) have emerged to be potent 
anti-inflammatory agents for auto-immune, allergic 
and inflammatory diseases. 
Objective: To investigate the effects of tri- 
chostatin A (TSA), a prototypica[ HDI, on pro- 
inflammatory cytokine expression by innate im- 
mune ceils exposed to microbial products. 
Methods: Mouse RAW 264.7, peritoneal and bone 
marrow-derived macrophages and dendritic ceils 
(DCs) and human whole blood were pre-incubated 
for 1 h with TSA (0-0.1 ~M) before stimulation with 
LPS, Pam3CSK4, peptidog[ycan, CpG DNA or heat- 
ki[[ed E. coli, S. aureus or C. albicans. Cytokine 
mRNA and protein expression were measured by 
Northern Noting and by ELISA. MHC II, CD40, CD80 
and CD86 expression by DCs was analyzed by flow 
cytometry. NF-kB activity was assessed by EMSA 
and transient transfection of RAW ceils with a kB- 
[uciferase reporter vector. Cytokine production was 
also measured 1 h after i.v. challenge with LPS 
(4~g/kg) and TSA (800~g/kg) in D-ga[actosamine- 
sensitized mice. 
Results: TSA was a potent inhibitor of TNF, IL-6 
and IL-12 production (up to 100% at 0.1 ~M TSA) 
by mouse macrophages, DCs and/or whole blood in 
response to a[[ microbial stimuli. TSA also strongly 
inhibited CD40 and CD86 up-regulation by DCs 
stimulated with LPS and Pam3CSK4. Inhibition of 
LPS and Pam3CSK4 induced TNF release by TSA- 
treated RAW 264.7 macrophages was associated 
with: (1) >75% inhibition of TNF mRNA levels, 
(2) reduced nuclear trans[ocation of NF-kB, and 
(3) marked inhibition (10-fold) of NF-kB-mediated 
transcriptional activity. In vivo, administration of 
TSA resulted in a striking inhibition (>90%, P =0.02) 
of LPS-induced IL-6 release. 
Conclusions: HDAC inhibitors exhibit profound in- 
hibitory effects on innate immune gene expres- 
sion by macrophages and dendritic ceils exposed 
to microbial products. These results suggest that 
HDI might be a new class of immunomodu[ators 
that deserve further investigation as anti-sepsis 
agents. Yet, these observations also suggest that 
HDI might impair innate immune defenses and thus 
predispose cancer patients who are treated with 
these agents to severe infections. 
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Inhibition of Histone Deacetylase 
Down-regulates Macrophage Migration Factor 
(MIF) Expression 
T. Roger*, X. Ding, D. Le Roy, A-L. Chanson, 
T. Ca[andra. In[ectious Diseases Service, CHUV, 
Lausanne, Switzerland 
Background: Increased expression or activity of 
histone deacety[ases (HDACs) have been detected 
in cancer ceils, which strengthened development 
of pharmacological inhibitors of HDACs (HDIs). HDIs 
were observed to induce the differentiation and 
the apoptosis of tumor ceils in vitro, so that several 
of these drugs are currently being tested as anti- 
cancer agents in clinical trials. Yet, the molecular 
basis of the anti-tumoral effects of HDIs is not 
fully understood. Macrophage migration inhibitory 
factor (MIF), a pro-inflammatory cytokine, has re- 
cently been implicated in ceil proliferation, angio- 
genesis and oncogenesis and may therefore repre- 
sent a novel target of HDI action. 
Objective: To study whether HDIs modify the ex- 
pression of MIF in human ceils. 
Methods: Human whole blood, HeLa cervix epithe- 
lial ceils, HaCat keratinocytes and U-937, KGla and 
HL-60 leukemic ceil lines were exposed to tricho- 
statin A (TSA), a prototypica[ HDI. MIF gene tran- 
scription, mRNA, protein and fuji-length, truncated 
or mutated promoter activities were assessed by 
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nuclear un on, Northern btotting, Western btotting 
and [uciferase reporter assay, respectivety. Tran- 
scription factor binding activity was assessed by 
EMSA and chromatin immunoprecipitation (CHIP). 
Results: TSA strongty reduced MIF mRNA and pro- 
tein revers in whore brood and cet[ tines. Nuctear 
run on anatyses showed that TSA reduced MIF gene 
transcription. Yet, TSA affected neither the activity 
of an ectopicatty expressed MIF promoter, nor the 
nuclear content of Spl and CREB, two transcription 
factors previousty shown to be indispensabte for 
MIF gene expression. Surprisingty, ChIP anatyses re- 
reared that, even though gtoba[ histone acetytation 
was strongty increased by TSA, TSA deacetytated 
the histories associated with the MIF promoter. This 
effect required protein synthesis and was coupted 
with a decreased recruitment of Spl and CREB to 
the bona fide MIF promoter. 
Conclusions: TSA down-regutates MIFexpression by 
a motecutar mechanism invotving a [oca[ deacety- 
ration of MIF-associated histories and a reduced 
transcription of the MIF gene. Considering that MIF 
is over-expressed in human tumors and required for 
tumor associated angiogenesis, our findings uggest 
that the anti-tumora[ effects of HDIs may be me- 
diated by a down-regutation f MIF expression. 
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Anti-Toll-Like Receptor 4 (TLR4) Antibodies 
Protect from Lethal Endotoxemia but not from 
Gram-negative Septic Shock 
T. Roger*, C. Froidevaux, D. Le Roy, M. Knaup- 
Reymond, D. Mauri, J. Tschopp, T. Catandra. 
Inl:ectious Diseases Service, CHUV, Lausanne 
Background: TLR4, an essentia[ signatting compo- 
nent of the LPS receptor comptex prays a criti- 
cat rote in innate immune defenses against Gram- 
negative (GN) bacteria, suggesting that it might be 
a candidate target for therapeutic nterventions in 
patients with GN septic shock. 
Objective: To investigate the effects of neutratiz- 
ing anti-TLR4 antibodies in murine modets of [etha[ 
endotoxemia and GN septic shock. 
Methods Rabbit anti-mTLR4 IgG, raised against a 
sotubte recombinant chimeric protein composed 
of the extracettutar domain of mouse TLR4 fused 
to the Fc domain of human IgG1 (mTLR4-Fc), or 
contro[ IgG were tested for their abitity: (1) to bind 
to mTLR4-Fc and native TLR4 by ELISA or FACS, 
(2) to inhibit LPS-induced cytokine production in 
whore brood assay or by primary macrophages, and 
(3) to protect OF1 mice from [etha[ endotoxemia 
(50 n8 of LPS i.v. with D-gatactosamine) or E. coti 
O18 sepsis (104-10 sCFU i.p.) with or without cef- 
tazidime (CAZ) (500 mg/kg i.v. 12-16 h after E. coti 
and then q12h). 
Results: Anti-mTLR4 IgG recognized mTLR4-Fc and 
macrophage TLR4, and inhibited LPS-induced TNF 
production in vitro. In vivo resutts are presented in
the tabte. 
Anti-TLR4 IgG Contro[ IgG 
TNF A[ive/tota[ TNF A[ive/tota[ 
(ng/m[) (surviva[) (ng/m[) (surviva[) 
LPS shock 0.13 16/17 (94%) + 1.3 7/15 (47%) + 
(0--0.65)* (0.05-20)* 
E. coli sepsis 0 (0-0.9) 0/6 (0%) 1.1 1/6 (17%) 
(w/o CAZ) (0.0-3.2) 
E. coil sepsis ND 1/22 (5%) ND 2/22 (9%) 
(with CAZ) 
IgG: 0.5-2.0mg 30min before LPS or 2-16h after E. coil; TNF: 
1 h after LPS, 3h after E. coil; ND: not done; *,+P<0.005. 
Conclusions: Anti-mTLR4 IgG protected mice from 
[etha[ endotoxemia, but not from Gram-negative 
septic shock. Thus, whereas TLR4 is critica[ for LPS 
sensing, other signatting pathways are atso acti- 
vated during Gram-negative s psis, suggesting that 
immunomodutating strategies just aimed at btock- 
ing TLR4 might not suffice to improve the outcome 
of patients with Gram-negative s ptic shock. 
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Role of Toll Like Receptors in Post Viral Disease 
R.W. Finberg*, J. Wang, D.R. Asher. University 
o]: Massachusetts Medical School, Worcester, MA, 
USA 
Background: Tot[ Like Receptors (TLRs) are pattern 
recognition proteins in mammatian cetts that are 
responsibte for the fever, hypotension, and shock 
that fottow some bacteria[ and vira[ infections. By 
serving as signa[ transduction proteins, TLRs rec- 
ognize foreign antigens in viruses and bacteria nd 
stimutate cetts to make cytokines. These cytokines 
are responsibte for the acute fever and other earty 
manifestations of infection. In addition, they are 
critica[ in the devetopment of the acquired immune 
response. White the rote of TLRs in the initia[ 
immune response has been documented for many 
different infections, tess studied has been the rote 
that these proteins have in virus associated "auto- 
immune" or post vira[ responses. 
Objectives: To investigate the rote of TLRs in the 
response to Coxsackie B3 virus. 
Methods: Human periphera[ brood [ymphocytes or
dendritic etts from inbred mice missing TLR genes 
were stimutated with Coxsackie B3 (CB3) virus with 
and without antibodies to CB3 and supernatants 
were assayed for the production of cytokines. 
